K
Kristina Miller
Researcher at London Health Sciences Centre
Publications - 8
Citations - 116
Kristina Miller is an academic researcher from London Health Sciences Centre. The author has contributed to research in topics: Mental illness & Mental health. The author has an hindex of 5, co-authored 8 publications receiving 78 citations. Previous affiliations of Kristina Miller include University of Western Ontario.
Papers
More filters
Journal ArticleDOI
Considerations in the use of reflective writing for student assessment: issues of reliability and validity.
Tracy Moniz,Shannon Arntfield,Kristina Miller,Lorelei Lingard,Christopher Watling,Glenn Regehr +5 more
TL;DR: Evidence to support the reliability and validity of reflective writing as a meaningful assessment strategy is lacking.
Journal ArticleDOI
Labelling of mental illness in a paediatric emergency department and its implications for stigma reduction education.
Javeed Sukhera,Kristina Miller,Alexandra Milne,Christina Scerbo,Rodrick Lim,Alicia Cooper,Christopher Watling +6 more
TL;DR: The confluence of socio-cultural, cognitive and emotional forces results in labelling of patients with mental illness as time-consuming, unpredictable and/or unfixable, which leads to unintentional avoidance behaviours from staff which are perceived as prejudicial and discriminatory by patients and caregivers.
Journal ArticleDOI
Implicit Stigma Recognition and Management for Health Professionals.
TL;DR: In this “in brief report,” the authors describe the evaluation of a novel implicit stigma reduction workshop for health professionals and suggest that it is a useful educational strategy for reducing stigma among health professionals.
Journal ArticleDOI
Advance care planning in community dwellers: A constructivist grounded theory study of values, preferences and conflicts.
Ravi Taneja,Lisa Faden,Valerie Schulz,Asha Rawal,Kristina Miller,Kristen A Bishop,Lorelei Lingard +6 more
TL;DR: Advance care planning for the healthy older adult is challenging and meaningful engagement must reflect what patients know and understand, their focus on unacceptable negative outcomes rather than interventions, and the need for iterative discussions with health-care providers.
Journal ArticleDOI
When Insulin Therapy Fails: The Impact of SGLT2 Inhibitors in Patients With Type 2 Diabetes.
TL;DR: The addition of sodium–glucose cotransporter 2 (SGLT2) inhibitors to a regimen of insulin therapy in this patient population has the potential to mitigate insulin-related weight gain and risk of hypoglycemia, with the added benefit of insulin dose reduction.